Trump Administration Sued Over Ban on Gender Transition Treatments in Federal Health Plans The Trump administration's decision to ban coverage for certain gender transition treatments in federal health plans has sparked widespread controversy and outrage among healthcare providers, advocacy groups, and transgender patients themselves.
At its core, the debate centers around whether federal health plans should cover medically necessary procedures for individuals seeking to transition.
Federal health plans, including Medicare and Medicaid, provide essential healthcare coverage for millions of Americans.